As this trend continues, it holds the promise of enhancing treatment options for patients and contributing to a more sustainable healthcare system.
For primary prevention settings, statins significantly lowered mortality risk (OR 0.91, 95% CI 0.830.99) and major coronary events (OR 0.69, 95% CI 0.610.79), although no significant differences were observed between individual statins
His scientific work has been focused on the regulatory peptides of the pancreas and the gut and their importance in the regulation of the functions of the GI-tract and metabolism, with particular focus on blood glucose and appetite regulation, obesity and diabetes
Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept
Many studies specifically demonstrate excellent outcomes in male populations